aTTom (adjuvant Tamoxifen--To offer more?): Randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer--Preliminary results
暂无分享,去创建一个
H. Earl | R. Gray | C. Poole | A. Marshall | K. Handley | M. Lee | P. Perry | A. Salman | D. Rea | M. Pritchard